The FDA issued EUA for first diagnostic test using at-home collection of saliva specimens
On May 8, 2020, the U.S. Food and Drug Administration (FDA) announced it had issued the first emergency…
-
-
RedHill Biopharma received FDA approval for COVID-19 clinical study with opaganib in the U.S.
On May 8, 2020, RedHill Biopharma announced the U.S. Food and Drug Administration (FDA) had approved its Investigational…
-
The CoVIg-19 Plasma Alliance was established
On May 8, 2020, the CoVIg-19 Plasma Alliance was announced, an unprecedented partnership of the world’s leading plasma…
-
Bharat Biotech leads a CSIR-NMITLI supported project to develop human antibodies or COVID-19 therapy
On May 8, 2020, the Council of Scientific and Industrial Research (CSIR) under its flagship programme NMITLI announced…
-
Risk factors for COVID-19 death revealed in world’s largest analysis of patient records to date
On May 7, 2020, academics at the University of Oxford and the London School of Hygiene & Tropical…
-
Sanger scientist received Chan Zuckerberg Initiative support for COVID-19 study
On May 7, 2020, the Wellcome Sanger Institute announced that Roser Vento-Tormo, a Group Leader was one of…
-
Gilead announces approval of Veklury (remdesivir) in Japan for patients with severe COVID-19
On May 7, 2020, Gilead announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | Medical Device | Non-Profit Research
OPTI Medical Systems received FDA Emergency Use Authorization for OPTI SARS-CoV-2 RNA PCR test kit for detection of Virus causing COVID-19
On May 7, 2020, OPTI Medical Systems, an IDEXX Laboratories subsidiary announced the U.S. Food and Drug Administration…
-
Tonix Pharma announced research collaboration and exclusive agreement with the University of Alberta to develop novel c-based vaccines for prevention of COVID-19
On May 7, 2020, Tonix Pharmaceuticals and the University of Alberta announced a research collaboration and exclusive licensing…
-
First large study of hydroxychloroquine does not support routine use in COVID-19 patients
On May 7, 2020, a study of nearly 1,400 patients with moderate to severe COVID-19 disease at a…
-
CoVIg-19 Plasma Alliance builds strong momentum through expanded membership and clinical trial collaboration
On May 7, 2020, the CoVId-19 Plasma Alliance, an unprecedented plasma industry collaboration recently established to accelerate the…
-
Entos Pharma partnered with Precision NanoSystems to enable scalable GMP manufacturing of Fusogenix DNA COVID-19 vaccine
On May 7, 2020, Entos Pharmaceuticals announced a partnership with Precision NanoSystems, Inc., (PNI), a global leader in…
-
Air Force Genetics Laboratory, DHA collaborate to further sequence SARS-CoV-2 code
On May 11, 2020, the Air Force Genetics Center of Excellence at Keesler Air Force Base announced it…
-
COVID-19 in-home monitoring program launched
On May 7, 2020, Washington University in St. Louis announced that people with COVID-19 who are seen by…
-
Royal DSM accelerated Dutch Covid-19 testing by making 28 million nose swabs
On May 7, 2020, Royal DSM announced it had started manufacturing nose swabs for the first time to…
-
NIH-supported research examines impact of COVID-19 on rare diseases community
On May 7, 2020, the National Institutes of Health (NIH) announced a new online survey launched by the…
-
Mesoblast announced first patients dosed in phase 2/3 trial for COVID-19 ARDS
On May 6, 2020, Mesoblast announced that the first patients were dosed in the 300-patient randomized placebo-controlled Phase…
-
Sinovac announced first animal study results of vaccine against COVID-19 published in SCIENCE
On May 6, 2020, Sinovac Biotech announced publication of the preclinical study on animals for its vaccine candidate…
-
UNMC researcher one of 12 in US to receive grant to study heart health related to COVID-19
On May 6, 2020, Rebekah Gundry, Ph.D., was one of only 12 investigators nationwide to receive a “COVID-19…
-
bioMerieux serology tests for SARS-CoV-2 on VIDAS underwent validation preceding launch
On May 6, 2020, bioMerieux announced performance validation and the upcoming launch of VIDAS® anti-SARS-CoV-2 serology tests to detect…
-
Laurent Pharmaceuticals received Health Canada’s approval to initiate COVID-19 clinical trial
On May 6, 2020, Laurent Pharmaceuticals announced that it has obtained the approval from Health Canada to initiate…
-
PharmaCyte Biotech received medical devices registration and submited pre-EUA application to the FDA for COVID-19 diagnostic kit
On May 6, 2020, PharmaCyte Biotech announced it had received Medical Devices Establishment Registration with the U.S. Food and…
-
3M and Ford begin shipping newly designed powered air-purifying respirators for health care workers fighting COVID-19
On May 6, 2020, 3M and Ford announced that newly designed powered air-purifying respirators (PAPRs), developed are on…
-
Meridian Bioscience partnered with QuantuMDx on COVID-19 assay
On May 6, 2020, Meridian Bioscience announced a collaboration with QuantuMDx on its newly launched SARS-CoV-2 assay for…
-
LabCorp announced availability of COVID-19 antibody test
On May 5, 2020, LabCorp announced that its COVID-19 Immunoglobulin G (IgG) antibody test is now available for…
-
Pfizer and BioNTech dosed first participants in US as part of global COVID-19 mRNA vaccine development program
On May 5, 2020, Pfizer and BioNTech announced the first participants have been dosed in the U.S. in…
-
Athersys announced commencement of patient enrollment in MACOVIA Study, a pivotal phase 2/3 trial evaluating MultiStem cell therapy for COVID-19 induced ARDS
On May 5, 2020, Athersys announced the first patients have been enrolled in Athersys’ pivotal Phase 2/3 study…
-
Miami University confirmed high quality of IGEA’s COVID-19 rapid test
On May 5, 2020, IGEA Pharma announced that an evaluation by the University of Miami Miller School of…
-
ACON Laboratories announced international availability of SARS-CoV-2 rapid test
On May 5, 2020, ACON Laboratories announced the availability of its SARS-COV-2 IgG/IgM Rapid Test. ACON’s test is…
-
Medigen Vaccine Biologics signed a license agreement with NIH on COVID-19 vaccine
On May 5, 2020, Medigen Vaccine Biologics Corp. (MVC) announced a global commercial license agreement with National Institutes…
